Question 1

What are the potential benefits of adding LSTA1 to my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this trial compare to other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits and treatments if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

Question 6

Can you explain the process of randomization and what it means for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma clinical trial (NCT05042128). Contact the study team or your healthcare provider for specific answers.

What this study is about